Literature DB >> 15531880

Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase.

Takumi Kamura1, Taichi Hara, Masaki Matsumoto, Noriko Ishida, Fumihiko Okumura, Shigetsugu Hatakeyama, Minoru Yoshida, Keiko Nakayama, Keiichi I Nakayama.   

Abstract

The cyclin-dependent kinase inhibitor p27(Kip1) is degraded at the G0-G1 transition of the cell cycle by the ubiquitin-proteasome pathway. Although the nuclear ubiquitin ligase (E3) SCF(Skp2) is implicated in p27(Kip1) degradation, proteolysis of p27(Kip1) at the G0-G1 transition proceeds normally in Skp2(-/-) cells. Moreover, p27(Kip1) is exported from the nucleus to the cytoplasm at G0-G1 (refs 9-11). These data suggest the existence of a Skp2-independent pathway for the degradation of p27(Kip1) at G1 phase. We now describe a previously unidentified E3 complex: KPC (Kip1 ubiquitination-promoting complex), consisting of KPC1 and KPC2. KPC1 contains a RING-finger domain, and KPC2 contains a ubiquitin-like domain and two ubiquitin-associated domains. KPC interacts with and ubiquitinates p27(Kip1) and is localized to the cytoplasm. Overexpression of KPC promoted the degradation of p27(Kip1), whereas a dominant-negative mutant of KPC1 delayed p27(Kip1) degradation. The nuclear export of p27(Kip1) by CRM1 seems to be necessary for KPC-mediated proteolysis. Depletion of KPC1 by RNA interference also inhibited p27(Kip1) degradation. KPC thus probably controls degradation of p27(Kip1) in G1 phase after export of the latter from the nucleus.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15531880     DOI: 10.1038/ncb1194

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  180 in total

Review 1.  microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis.

Authors:  Martin Busch; Alma Zernecke
Journal:  J Mol Med (Berl)       Date:  2012-02-04       Impact factor: 4.599

2.  The coronavirus endoribonuclease Nsp15 interacts with retinoblastoma tumor suppressor protein.

Authors:  Kanchan Bhardwaj; Pinghua Liu; Julian L Leibowitz; C Cheng Kao
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

3.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Authors:  Jessie Villanueva; Yuval Yung; Janice L Walker; Richard K Assoian
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

4.  P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases.

Authors:  Debora Bencivenga; Annunziata Tramontano; Alessia Borgia; Aide Negri; Ilaria Caldarelli; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione; Adriana Borriello
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  G0 function of BCL2 and BCL-xL requires BAX, BAK, and p27 phosphorylation by Mirk, revealing a novel role of BAX and BAK in quiescence regulation.

Authors:  Yelena Janumyan; Qinghua Cui; Ling Yan; Courtney G Sansam; Mayda Valentin; Elizabeth Yang
Journal:  J Biol Chem       Date:  2008-09-25       Impact factor: 5.157

6.  Upregulation of CRM1 relates to neuronal apoptosis after traumatic brain injury in adult rats.

Authors:  Aihong Li; Feihui Zou; Hongran Fu; Gang Cui; Yaohua Yan; Qiyun Wu; Xingxing Gu
Journal:  J Mol Neurosci       Date:  2013-03-15       Impact factor: 3.444

7.  Antitumor bioactivity of adenovirus-mediated p27mt in colorectal cancer cell line SW480.

Authors:  Ze-Qun Sun; Chang-Sheng Deng; Shao-Yong Xu; Yong Du
Journal:  World J Gastroenterol       Date:  2008-10-14       Impact factor: 5.742

8.  A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression.

Authors:  Arnaud Besson; Mark Gurian-West; Xueyan Chen; Karen S Kelly-Spratt; Christopher J Kemp; James M Roberts
Journal:  Genes Dev       Date:  2006-01-01       Impact factor: 11.361

9.  Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradation.

Authors:  Cristina E Tognon; Bo Rafn; Naniye Malli Cetinbas; Takumi Kamura; Genny Trigo; Barak Rotblat; Fumihiko Okumura; Masaki Matsumoto; Christine Chow; Monika Davare; Michael Pollak; Thibault Mayor; Poul H Sorensen
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

10.  CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.

Authors:  Ruiying Zhao; Heng-Yin Yang; Jihyun Shin; Liem Phan; Lekun Fang; Ting-Fang Che; Chun-Hui Su; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.